Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes

被引:2
|
作者
Tauschmann, Martin [1 ,2 ]
Hovorka, Roman [1 ,2 ]
机构
[1] Univ Cambridge, Wellcome Trust MRC Inst Metab Sci, Cambridge, England
[2] Univ Cambridge, Dept Paediat, Cambridge, England
基金
欧盟地平线“2020”; 英国惠康基金;
关键词
Threshold-based insulin interruption; low glucose suspension; predictive low glucose suspension; artificial pancreas; closed-loop system; type; 1; diabetes; control algorithm; insulin pump; continuous glucose monitor; CLOSED-LOOP CONTROL; SENSOR-AUGMENTED PUMP; UNIFIED SAFETY SYSTEM; ARTIFICIAL PANCREAS; HOME-USE; GLYCEMIC EXCURSIONS; SUSPEND FUNCTION; BIONIC PANCREAS; HYPOGLYCEMIA; OVERNIGHT;
D O I
10.1080/17425247.2017.1360866
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Nocturnal glucose control remains challenging in children and adolescents with type 1 diabetes due to highly variable overnight insulin requirements. The issue may be addressed by glucose responsive insulin delivery based on real-time continuous glucose measurements. Areas covered: This review outlines recent developments of glucose responsive insulin delivery systems from a paediatric perspective. We cover threshold-based suspend application, predictive low glucose suspend, and more advanced single hormone and dual-hormone closed-loop systems. Approaches are evaluated in relation to nocturnal glucose control particularly during outpatient randomised controlled trials. Expert opinion: Significant progress translating research from controlled clinical centre settings to free-living unsupervised home studies have been achieved over the past decade. Nocturnal glycaemic control can be improved whilst reducing the risk of hypoglycaemia with closed-loop systems. Following the US regulatory approval of the first hybrid closed-loop system in non-paediatric population, large multinational closed-loop clinical trials and pivotal studies including paediatric populations are underway or in preparation to facilitate the use of closed-loop systems in clinical practice.
引用
收藏
页码:1367 / 1377
页数:11
相关论文
共 50 条
  • [1] Pharmacokinetics, prandial glucose control, and safely of insulin glulisine in children and adolescents with type 1 diabetes
    Danne, T
    Becker, RHA
    Heise, T
    Bittner, C
    Frick, AD
    Rave, K
    [J]. DIABETES CARE, 2005, 28 (09) : 2100 - 2105
  • [2] Insulin-delivery methods for children and adolescents with type 1 diabetes
    Zuberi, Zavuga
    Sauli, Elingarami
    Cun, Liu
    Deng, Jing
    Li, Wen-Jun
    He, Xu-Liang
    Li, Wen
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2020, 11
  • [3] Predictors of glucose control in children and adolescents with type 1 diabetes mellitus
    Urbach, SL
    LaFranchi, S
    Lambert, L
    Lapidus, JA
    Daneman, D
    Becker, TM
    [J]. PEDIATRIC DIABETES, 2005, 6 (02) : 69 - 74
  • [4] Implications of Nocturnal Hypertension in Children and Adolescents With Type 1 Diabetes
    Lee, Sun Hee
    Kim, Jae Hyun
    Kang, Min Jae
    Lee, Young Ah
    Yang, Sei Won
    Shin, Choong Ho
    [J]. DIABETES CARE, 2011, 34 (10) : 2180 - 2185
  • [5] Effect of Continuous Glucose Monitoring and Automated Insulin Delivery System on Glycemic Control in Children with Type 1 Diabetes
    Tantivit, Nessa
    Kaulfers, Anne-Marie
    Mulekar, Madhuri
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 3): : 57 - 59
  • [6] Closed-loop insulin delivery systems in children and adolescents with type 1 diabetes
    Dovc, Klemen
    Battelino, Tadej
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (02) : 157 - 166
  • [7] GLUCOSE CONTROL DURING EXERCISE USING AUTOMATED INSULIN DELIVERY IN TYPE 1 DIABETES
    Dovc, K.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A8 - A8
  • [9] Comparing dual-hormone and single-hormone automated insulin delivery systems on nocturnal glucose management among children and adolescents with type 1 diabetes: A pooled analysis
    Wu, Zekai
    Lebbar, Maha
    Taleb, Nadine
    Legault, Laurent
    Messier, Virginie
    Rabasa-Lhoret, Remi
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 310 - 313
  • [10] Insulin therapy in children and adolescents with Type 1 diabetes
    McAssey, K
    Perlman, K
    Daneman, D
    [J]. DIABETES NUTRITION & METABOLISM, 1999, 12 (02) : 86 - 95